Companies Bicycle Therapeutics

A new approach to precision-guided therapies


Bicycles are a new kind of novel molecule. Named for their bi-cyclic peptide structure, bicycles can deliver high precision to their chosen targets, while their size and surface area means they can potentially engage targets that have historically been resistant to conventional modalities. They are designed to address significant unmet medical needs in patients.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More